Drug Delivery Implants in the Treatment of Vitreous Inflammation
The eye is a model organ for the local delivery of therapeutics. This proves beneficial when treating vitreous inflammation and other ophthalmic pathologies. The chronicity of certain diseases, however, limits the effectiveness of locally administered drugs. To maintain such treatments often require...
Main Authors: | Jillian Wang, Angela Jiang, Malav Joshi, John Christoforidis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/780634 |
Similar Items
-
Systemic Treatments for Noninfectious Vitreous Inflammation
by: Angela Jiang, et al.
Published: (2013-01-01) -
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
by: Shivi Agrawal, et al.
Published: (2013-01-01) -
Systemic Treatment of Vitreous Inflammation
by: John B. Christoforidis, et al.
Published: (2012-01-01) -
Intravitreal Devices for the Treatment of Vitreous Inflammation
by: John B. Christoforidis, et al.
Published: (2012-01-01) -
A model of ageing vitreous : implications for drug delivery
by: Tan, Lay Ean
Published: (2010)